Debjit Chattopadhyay
Stock Analyst at Guggenheim
(4.79)
# 528
Out of 4,468 analysts
663
Total ratings
49.3%
Success rate
17.6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Debjit Chattopadhyay
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NGNE Neurogene | Maintained: Buy | $69 | $35.34 | +95.25% | 3 | Jun 30, 2026 | |
| TSX: MSCL Satellos Bioscience Inc. | Maintained: Buy | $32.66 | $10.91 | +199.33% | 3 | Jun 30, 2026 | |
| EWTX Edgewise Therapeutics | Maintained: Buy | $41 | $39.56 | +3.64% | 4 | Jun 17, 2026 | |
| SPRB Spruce Biosciences | Initiated Coverage: Buy | $123 | $52.51 | +134.24% | 1 | Jun 16, 2026 | |
| RZLT Rezolute | Rated: Buy | $6 → $11 | $4.91 | +124.03% | 5 | Jun 15, 2026 | |
| BNTC Benitec Biopharma | Downgraded: Hold | n/a | $13.22 | - | 2 | Jun 10, 2026 | |
| NTLA Intellia Therapeutics | Rated: Hold | n/a | $17.56 | - | 7 | Jun 10, 2026 | |
| PASG Passage Bio | Downgraded: Hold | n/a | $4.68 | - | 6 | Jun 10, 2026 | |
| PEPG PepGen | Reiterated: Buy | $7 | $1.76 | +297.73% | 4 | Jun 8, 2026 | |
| TRDA Entrada Therapeutics | Maintained: Buy | $20 → $17 | $7.72 | +120.21% | 3 | Jun 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $4.23 | +278.25% | 1 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 | $3.78 | +482.01% | 24 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 | $8.18 | +132.27% | 16 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $52 → $43 | $33.47 | +28.47% | 5 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 | $34.83 | +29.20% | 4 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $284 | $375.07 | -24.28% | 8 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $26 | $10.84 | +139.85% | 1 | Mar 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $46 → $58 | $31.26 | +85.54% | 4 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 → $39 | $33.86 | +15.18% | 2 | Dec 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $30 | $4.69 | +539.66% | 1 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 → $95 | $41.81 | +127.22% | 64 | Sep 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $64 → $92 | $81.80 | +12.47% | 10 | Sep 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $19.28 | +14.11% | 101 | Sep 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $5 | $3.87 | +29.20% | 3 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $110 → $106 | $58.99 | +79.69% | 8 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $450 → $546 | $528.04 | +3.40% | 7 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $78 → $55 | $34.79 | n/a | 5 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 → $50 | $23.07 | n/a | 6 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $60.08 | n/a | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $312.78 | n/a | 3 | Jun 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 → $24 | $6.53 | n/a | 2 | Apr 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $3.65 | n/a | 1 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $14 → $16 | $0.0749 | n/a | 10 | Jan 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $30.43 | n/a | 14 | Sep 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $6.26 | n/a | 19 | Sep 1, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $32.70 | n/a | 8 | Aug 31, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | CHF 25.00 | $3.18 | n/a | 7 | Aug 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $270 → $123 | $30.39 | n/a | 19 | Aug 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36 → $30 | $13.09 | n/a | 20 | Aug 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $13 | $37.93 | n/a | 19 | Aug 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $1.58 | n/a | 20 | Aug 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $2.92 | n/a | 4 | Aug 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $54 | $26.31 | n/a | 10 | Aug 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $49 | $2.08 | n/a | 6 | Aug 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $4.35 | n/a | 5 | Aug 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $4.71 | n/a | 45 | Jul 31, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $32 → $26 | $71.04 | n/a | 50 | May 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2 | $15.42 | n/a | 15 | Dec 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $37.59 | n/a | 9 | Aug 1, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Sell | $7 | $90.21 | n/a | 1 | Dec 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $9 → $1.5 | $2.09 | n/a | 5 | Oct 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $7.5 → $10 | $15.16 | n/a | 23 | Oct 26, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $63 | $83.31 | n/a | 19 | Oct 16, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 | $0.42 | n/a | 7 | Aug 16, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $16 | $7.28 | n/a | 13 | Aug 14, 2015 |
Neurogene
Jun 30, 2026
Maintained: Buy
Price Target: $69
Current: $35.34
Upside: +95.25%
Satellos Bioscience Inc.
Jun 30, 2026
Maintained: Buy
Price Target: $32.66
Current: $10.91
Upside: +199.33%
Edgewise Therapeutics
Jun 17, 2026
Maintained: Buy
Price Target: $41
Current: $39.56
Upside: +3.64%
Spruce Biosciences
Jun 16, 2026
Initiated Coverage: Buy
Price Target: $123
Current: $52.51
Upside: +134.24%
Rezolute
Jun 15, 2026
Rated: Buy
Price Target: $6 → $11
Current: $4.91
Upside: +124.03%
Benitec Biopharma
Jun 10, 2026
Downgraded: Hold
Price Target: n/a
Current: $13.22
Upside: -
Intellia Therapeutics
Jun 10, 2026
Rated: Hold
Price Target: n/a
Current: $17.56
Upside: -
Passage Bio
Jun 10, 2026
Downgraded: Hold
Price Target: n/a
Current: $4.68
Upside: -
PepGen
Jun 8, 2026
Reiterated: Buy
Price Target: $7
Current: $1.76
Upside: +297.73%
Entrada Therapeutics
Jun 5, 2026
Maintained: Buy
Price Target: $20 → $17
Current: $7.72
Upside: +120.21%
Jun 4, 2026
Initiated Coverage: Buy
Price Target: $16
Current: $4.23
Upside: +278.25%
Jun 2, 2026
Maintained: Buy
Price Target: $22
Current: $3.78
Upside: +482.01%
May 28, 2026
Maintained: Buy
Price Target: $19
Current: $8.18
Upside: +132.27%
May 8, 2026
Maintained: Buy
Price Target: $52 → $43
Current: $33.47
Upside: +28.47%
May 7, 2026
Maintained: Buy
Price Target: $45
Current: $34.83
Upside: +29.20%
May 4, 2026
Reiterated: Buy
Price Target: $284
Current: $375.07
Upside: -24.28%
Mar 20, 2026
Initiated Coverage: Buy
Price Target: $26
Current: $10.84
Upside: +139.85%
Mar 4, 2026
Rated: Buy
Price Target: $46 → $58
Current: $31.26
Upside: +85.54%
Dec 3, 2025
Maintained: Buy
Price Target: $32 → $39
Current: $33.86
Upside: +15.18%
Oct 15, 2025
Initiated Coverage: Buy
Price Target: $30
Current: $4.69
Upside: +539.66%
Sep 24, 2025
Maintained: Buy
Price Target: $28 → $95
Current: $41.81
Upside: +127.22%
Sep 22, 2025
Maintained: Buy
Price Target: $64 → $92
Current: $81.80
Upside: +12.47%
Sep 15, 2025
Reiterated: Buy
Price Target: $22
Current: $19.28
Upside: +14.11%
Aug 13, 2025
Maintained: Buy
Price Target: $20 → $5
Current: $3.87
Upside: +29.20%
Aug 6, 2025
Maintained: Buy
Price Target: $110 → $106
Current: $58.99
Upside: +79.69%
Aug 6, 2025
Maintained: Buy
Price Target: $450 → $546
Current: $528.04
Upside: +3.40%
May 7, 2025
Maintained: Buy
Price Target: $78 → $55
Current: $34.79
Upside: n/a
Aug 14, 2024
Maintained: Buy
Price Target: $45 → $50
Current: $23.07
Upside: n/a
Jun 28, 2024
Rated: Hold
Price Target: n/a
Current: $60.08
Upside: n/a
Jun 27, 2022
Downgraded: Hold
Price Target: n/a
Current: $312.78
Upside: n/a
Apr 5, 2022
Maintained: Buy
Price Target: $28 → $24
Current: $6.53
Upside: n/a
Mar 17, 2021
Initiated Coverage: Hold
Price Target: n/a
Current: $3.65
Upside: n/a
Jan 6, 2021
Initiated Coverage: Hold
Price Target: $14 → $16
Current: $0.0749
Upside: n/a
Sep 3, 2020
Reiterated: Buy
Price Target: $17
Current: $30.43
Upside: n/a
Sep 1, 2020
Maintained: Buy
Price Target: $20
Current: $6.26
Upside: n/a
Aug 31, 2020
Reiterated: Buy
Price Target: $30
Current: $32.70
Upside: n/a
Aug 28, 2020
Reiterated: Buy
Price Target: CHF 25.00
Current: $3.18
Upside: n/a
Aug 24, 2020
Downgraded: Hold
Price Target: $270 → $123
Current: $30.39
Upside: n/a
Aug 11, 2020
Maintained: Buy
Price Target: $36 → $30
Current: $13.09
Upside: n/a
Aug 10, 2020
Reiterated: Hold
Price Target: $13
Current: $37.93
Upside: n/a
Aug 7, 2020
Reiterated: Buy
Price Target: $24
Current: $1.58
Upside: n/a
Aug 6, 2020
Reiterated: Buy
Price Target: $42
Current: $2.92
Upside: n/a
Aug 6, 2020
Maintained: Buy
Price Target: $54
Current: $26.31
Upside: n/a
Aug 6, 2020
Reiterated: Buy
Price Target: $49
Current: $2.08
Upside: n/a
Aug 6, 2020
Reiterated: Buy
Price Target: $25
Current: $4.35
Upside: n/a
Jul 31, 2020
Reiterated: Buy
Price Target: $40
Current: $4.71
Upside: n/a
May 12, 2020
Reiterated: Hold
Price Target: $32 → $26
Current: $71.04
Upside: n/a
Dec 18, 2019
Maintained: Buy
Price Target: $2
Current: $15.42
Upside: n/a
Aug 1, 2017
Maintained: Hold
Price Target: n/a
Current: $37.59
Upside: n/a
Dec 20, 2016
Initiated Coverage: Sell
Price Target: $7
Current: $90.21
Upside: n/a
Oct 20, 2016
Maintained: Hold
Price Target: $9 → $1.5
Current: $2.09
Upside: n/a
Oct 26, 2015
Initiated Coverage: Buy
Price Target: $7.5 → $10
Current: $15.16
Upside: n/a
Oct 16, 2015
Maintained: Hold
Price Target: $63
Current: $83.31
Upside: n/a
Aug 16, 2015
Maintained: Buy
Price Target: $4
Current: $0.42
Upside: n/a
Aug 14, 2015
Reiterated: Buy
Price Target: $10 → $16
Current: $7.28
Upside: n/a